Iovance Biotherapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Iovance Biotherapeutics Inc
CIK #0001425205
EDGAR Form CIK 2011 - 2025
10-K [0001425205]
10-Q [0001425205]
3 [0001425205]
4 [0001425205]
5 [0001425205]
8-K [0001425205]
D [0001425205]
SC 13D [0001425205]
SC 13G [0001425205]
Form 13D/13G Filer Form 13D/13G Subject Filed
Perceptive Advisors LLC Iovance Biotherapeutics Inc [2024-03-01]
Point72 Asset Management LP Iovance Biotherapeutics Inc [2023-02-17]
BlackRock Inc Iovance Biotherapeutics Inc [2023-02-03]
State Street Corp Iovance Biotherapeutics Inc [2023-02-02]
MHR Fund Management LLC Iovance Biotherapeutics Inc [2022-12-30]
Wellington Management Group LLP Iovance Biotherapeutics Inc [2022-02-04]
ARK Investment Management LLC Iovance Biotherapeutics Inc [2021-01-11]
Price T Rowe Associates Inc /MD/ Iovance Biotherapeutics Inc [2020-02-14]
Vanguard Group Inc Iovance Biotherapeutics Inc [2020-02-11]
Acuta Capital Partners LLC Iovance Biotherapeutics Inc [2019-02-14]
Perceptive Advisors LLC Iovance Biotherapeutics Inc [2019-02-14]
Acuta Capital Partners LLC Iovance Biotherapeutics Inc [2018-02-14]
Broadfin Capital LLC Iovance Biotherapeutics Inc [2018-02-13]
BlackRock Inc Iovance Biotherapeutics Inc [2018-01-25]
Acuta Capital Partners LLC Lion Biotechnologies Inc [2017-02-13]
OrbiMed Advisors LLC Lion Biotechnologies Inc [2017-02-13]
Franklin Resources Inc Lion Biotechnologies Inc [2017-02-07]
Quogue Capital LLC Lion Biotechnologies Inc [2016-06-13]
RS Investment Management Co LLC Lion Biotechnologies Inc [2016-02-12]
venBio Select Advisor LLC Lion Biotechnologies Inc [2016-02-12]
Broadfin Capital LLC Lion Biotechnologies Inc [2016-02-11]
BlackRock Inc Lion Biotechnologies Inc [2016-01-28]
Perceptive Advisors LLC Lion Biotechnologies Inc [2015-02-17]
FMR LLC Lion Biotechnologies Inc [2014-07-10]
Alpha Capital Anstalt Lion Biotechnologies Inc [2014-01-02]
Ayer Capital Management LP Genesis Biopharma Inc [2013-06-03]
[2013-01-09]
Form 3/4/5 Subject 2011 - 2025
Iovance Biotherapeutics Inc
Roche Corleen M.
Rosinack Matthew W.
Weiser Michael
Dukes Iain D.
Yarno Wendy L
Countouriotis Athena
Maynard Ryan D
Kirby Daniel Gordon
Bellemin Jean-Marc
View All
Terms | Privacy | Guide
tony@aum13f.com